Table 2 Frequency of hypertension, dyslipidemia, and use of medication in patients with and without Takayasu’s arteritis activity
Variables | Without activity N = 21 N (%) | With activity N = 9 N (%) | p |
|---|---|---|---|
Hypertension | 16 (76.2) | 07 (77.8) | 1.00 |
Dyslipidemia | 12 (57.1) | 06 (66.7) | 0.704 |
Statins | 11 (52.4) | 05 (55.6) | 1.00 |
ACE inhibitors | 10 (47.6) | 05 (55.6) | 1.00 |
ARB | 02 (9.5) | 01 (11.1) | 1.00 |
Beta-blockers | 05 (23.8) | 04 (44.4) | 0.389 |
Calcium channel blockers | 05 (23.8) | 03 (33.3) | 0.666 |
Acetyl salicylic acid | 21 (100) | 09 (100) | 1.00 |
Prednisone | 16 (76.2) | 07 (77.8) | 0.166 |
Dose ≤5 mg: 06 (37.5) | Dose ≤5 mg: 0 | ||
Dose > 5 mg: 10 (62.5) | Dose > 5 mg: 07 (100) | ||
Immunosuppressive drugs | 17 (80,9) | 07 (77,7) | 1,00 |
Leflunomide: 06 (35) | Leflunomide: 05 (71,4) | 0,225 | |
Methotrexate: 09 (53) | Methotrexate: 01(14,2) | 0,204 | |
Azathioprine: 02 (12) | Azathioprine: 01 (14,2) | 1,00 | |
users of anti-TNF | 03 (14,2) | 02 (22,2) | 0,622 |